#clinical trial

Dana-Farber researchers explore CAR-T therapy and next generation immunotherapy to target colorectal cancer.

With federal funds, Florida State University’s College of Nursing will lead the Adolescent Medicine Trials Network for HIV Interventions.

A team of experts on acute promyelocytic leukemia (APL) were available by phone or email to other oncologists treating this rare cancer.

Women—especially Black women—are underrepresented in late-stage studies of new HIV therapies.

The Dana-Farber led ALPINE trial looked at the drug in relapsed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

“I worry for my patients,” says a researcher at the Chicago CORE center. The pause also affects trials for cancer, COVID and mpox.

This lack of representation results in findings that cannot be applied to the broader population.

EBT-101 is novel gene-editing therapy that uses “molecular scissors” to cut HIV out of cells.

A personalized cancer vaccine plus Keytuda lowered the risk of melanoma coming back after surgery.

The new director of the National Cancer Institute says her prognosis is very favorable.

Genomic testing is an important tool to guide treatment decisions among women with early-stage breast cancer.

Black people make up only 6% and Latino people make up 5% of participants in cirrhosis trials in the United States.

UPDATE: On October 25, the FDA approved Tecvayli (teclistamab) to treat some people with multiple myeloma.

Starting January 1, 2023, more Californians will have access to cancer care and services, such as genome testing and clinical trials.

University of California San Francisco hosted First Lady Jill Biden to speak about the Cancer Moonshot and breast cancer research.